L
Lori C. Jordan
Researcher at Vanderbilt University Medical Center
Publications - 210
Citations - 16498
Lori C. Jordan is an academic researcher from Vanderbilt University Medical Center. The author has contributed to research in topics: Stroke & Pediatric stroke. The author has an hindex of 38, co-authored 186 publications receiving 11933 citations. Previous affiliations of Lori C. Jordan include Veterans Health Administration & University of California, Los Angeles.
Papers
More filters
Journal ArticleDOI
Randomized controlled trial of fixed low-vs moderate-dose hydroxyurea for primary stroke prevention in Sub-Saharan Africa: Final results of the Spring Trial
Shehu U. Abdullahi,Binta W. Jibir,Halima Bello-Manga,Safiya Gambo,Hauwa Inuwa,Aliyu Tijjani,Aisha Amal Galadanci,Awwal Musa Borodo,Najibah A. Galadanci,Nura Idris,Abulkadir M Tabari,Lawal Haliru,Khadija Bulama,Gloria Bahago,Mohammed A. Sani,Aisha A. Suleiman,Murtala Umar,Charity Dooshima,Aisha Kazaure,Bilya Sani Musa,Fahad M Usman,Abdulrasheed Sani,Awwal Gambo,Jamila Sani Ibrahim,Mustapha Shuaibu Hikima,Aisha B. Musa,Abdu Hamisu Dambatta,Jamil Galadanci,Brittany Covert Greene,Djamila L. Ghafuri,Mark Rodeghier,James C. Slaughter,Fenella J. Kirkham,Kathleen A. Neville,Adetola A. Kassim,Muktar H. Aliyu,Lori C. Jordan,Edwin Trevathan,Michael R. DeBaun +38 more
TL;DR: Testing the hypothesis that fixed-moderate dose hydroxyurea therapy for primary stroke prevention results in a 66% relative risk reduction when compared to fixed low-dose hydroxyUREa therapy in a randomized controlled trial, found it to be effective.
Journal ArticleDOI
Using novel magnetic resonance imaging methods to predict stroke risk in individuals with sickle cell anemia.
Lori C. Jordan,Adetola A. Kassim,Karina L Wilkerson,Chelsea A Lee,Spencer L. Waddle,Manus J. Donahue +5 more
TL;DR: This review focuses on using advanced neuroimaging methods to assess stroke risk in individuals with SCA and such methods may be utilized before and after bone marrow or hematopoietic stem cell transplant to assess cerebral hemodynamic response.
Journal ArticleDOI
Advances in neuroimaging to improve care in sickle cell disease.
TL;DR: Sickle cell disease is associated with progressive and increased neurological morbidity throughout the lifespan as discussed by the authors, and silent cerebral infarcts are found in more than a third of adolescents by age 18 years and roughly half of young adults by age 30 years.
Journal ArticleDOI
The Contribution of Common Surgically Implanted Hardware to Functional MR Imaging Artifacts.
Aditi A. Desai,Megan K. Strother,Carlos C Faraco,Victoria L. Morgan,Travis R. Ladner,Lindsey M. Dethrage,Lori C. Jordan,Manus J. Donahue +7 more
TL;DR: Blood oxygenation level–dependent MR imaging yields interpretable functional maps in most patients beyond a small (30–40 cm3) artifact surrounding the hardware, which is increasingly used clinically to noninvasively assess cerebrovascular reactivity and/or language and motor function.
Journal ArticleDOI
Hydroxyurea for secondary stroke prevention in children with sickle cell anemia in Nigeria: a randomized controlled trial
Shehu U. Abdullahi,Surayya M. Sunusi,Mohammed Abba,Saifuddeen Sani,Hauwau Aminu Inuwa,Safiya Gambo,Awwal Gambo,Bilya Sani Musa,Brittany Covert Greene,Adetola A. Kassim,Mark Rodeghier,Nafiu Hussaini,Mariana Ciobanu,Muktar H. Aliyu,Lori C. Jordan,Michael Dean +15 more
TL;DR: In this article , both low and moderate doses of hydroxyurea are efficacious for secondary stroke prevention in low-resource settings, and the median time between the initial stroke and death was less than a year, 0.8 years.